| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,067 |
12,816 |
$1.23M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,220 |
2,220 |
$305K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,546 |
3,517 |
$135K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,558 |
1,540 |
$114K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,077 |
1,073 |
$89K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,146 |
3,019 |
$85K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,043 |
5,001 |
$71K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
352 |
352 |
$32K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
714 |
710 |
$22K |
| 99051 |
|
397 |
394 |
$3K |
| 96136 |
|
55 |
55 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
133 |
132 |
$2K |
| 87807 |
|
144 |
143 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
33 |
33 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
29 |
29 |
$767.17 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
58 |
57 |
$44.39 |